Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-17-005576
Filing Date
2017-02-10
Accepted
2017-02-10 09:39:12
Documents
1
Group Members
PHASE4 VENTURES III GENERAL PARTNER LTDPHASE4 VENTURES III GP LPPHASE4 VENTURES III LP

Document Format Files

Seq Description Document Type Size
1 PHASE4 PARTNERS LTD SC 13GA 12-31-2016 (NABRIVA THERAPEUTICS AG) formsc13ga.htm SC 13G/A 110484
  Complete submission text file 0001140361-17-005576.txt   112096
Mailing Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ
Business Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ 44 0 20 3036 0050
Phase4 Partners Ltd (Filed by) CIK: 0001600023 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

EIN.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 17590002
SIC: 2834 Pharmaceutical Preparations